Novartis Consumer Health and FDA notified patients, pharmacists and other healthcare professionals that the sponsor is conducting a nationwide voluntary recall of all Triaminic Vapor Patch products due to reports of serious adverse events associated with accidental ingestion by children. Triaminic Vapor Patch is labeled as a cough suppressant for children two (2) years of age and older and is sold over the counter at pharmacies and retail outlets nationwide. The directions on the label indicate the patch is to be applied to the throat or chest to allow the vapors to reach the nose and mouth. FDA is warning consumers not to use the Triaminic Vapor Patch and is also advising consumers who have used the product and have concerns or questions to contact their physician or health care practitioner.
Comments are closed.